Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_provenance.
• NP349126.RAotaKXuar0R1isYrH971JODXuwaktvY9N26eyFxWbf64130_assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349126.RAotaKXuar0R1isYrH971JODXuwaktvY9N26eyFxWbf64130_provenance.
• NP349136.RAj_q6iZOJBEmMezoUUT2kcFWjnoQQtfXzsPQLyZP3Y_8130_assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349136.RAj_q6iZOJBEmMezoUUT2kcFWjnoQQtfXzsPQLyZP3Y_8130_provenance.
• NP971618.RAGIuZmnlmLILW8wEKBTNgBQOzJaGpvnSpBj8xnJB1_PA130_assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971618.RAGIuZmnlmLILW8wEKBTNgBQOzJaGpvnSpBj8xnJB1_PA130_provenance.
• NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_provenance.
• NP971619.RA_ItCrUlXQGl-ZT-VyZY2D_BNsz3Fkkmyg1nHB2ypGJc130_assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971619.RA_ItCrUlXQGl-ZT-VyZY2D_BNsz3Fkkmyg1nHB2ypGJc130_provenance.